ABI Says SOLiD Found More Forms of Variation in HapMap than Illumina; No Formal Comparison Yet | GenomeWeb

By Julia Karow

Applied Biosystems' SOLiD platform discovered more forms of genome variation in a HapMap sample with less coverage than Illumina's Genome Analyzer did in a previous analysis of the same sample, although the overall number of variations discovered was smaller, according to an ABI researcher. However, a formal comparison of the two studies — which both used sequencing platforms that have since improved — has not been published to date.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.